Navigation Links
C O R R E C T I O N -- Osteotech, Inc.
Date:7/29/2009

n programs focused on highlighting the superior characteristics of our broad technology platforms and product portfolios. From a trajectory perspective, we are looking forward to the release of our new product pipeline in the second half in 2009."

Recent 2009 Corporate Developments

  • Osteotech completed the 60-patient enrollment for its DuraTech clinical trial. In the initial feedback from physicians participating in the trial, DuraTech was characterized as a unique, easy to use solution that possesses several important characteristics making it ideal as an onlay graft. Based upon this timely completion of trial enrollment, the Company remains on track to file a 510(k) with the U.S. Food and Drug Administration in the third quarter of this year to secure marketing clearance for DuraTech. The Company also continues to expect to unveil DuraTech at the 2009 Annual Meeting of the Congress of Neurological Surgeons in October. DuraTech is the first of several products under development based upon Osteotech's proprietary human collagen technology (HCT(TM)) platform.

  • During the second quarter, the Company completed its six month posterolateral fusion study of its proprietary MagniFuse Bone Graft in primates. The Company also completed its six month sheep study focused on interbody fusion, comparing MagniFuse directly with INFUSE(R) Bone Graft distributed by Medtronic, Inc. The initial analysis of the data indicates that MagniFuse was able to produce robust bone formation in both models. Of particular significance was the ability of MagniFuse to produce similar results against INFUSE in interbody fusion. Osteotech is currently compiling the histological results for both studies for inclusion in a clinical data package to be available later this year. These studies support the Company's strategy to introduce application-specific products with documented scientific and te
    '/>"/>

SOURCE Osteotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Mass., (PRWEB) September 01, 2014 BCC ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , ... $21.8 million in 2013 and is expected to reach ... grow to $471.5 million by 2019, which is equivalent ... through 2019. The receptor-mediated transport (RMT) segment is forecasted ...
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ... status conference in September, where issues related to claims ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... on the Court’s website, the meeting is scheduled to ... This is the latest of several Tylenol conferences that ...
(Date:9/1/2014)... Ontraport , one of the latest ... to automate the small intricacies of managing an online ... prompting an investigative review. , “As a new ... all of the small details involved with running a ... “That’s why Ontraport has become so popular in this ...
(Date:9/1/2014)... Diego, CA (PRWEB) September 01, 2014 ... daily regarding all the latest information from the FDA ... , The US FDA announced on August 28, that ... recalled (Class I) as the device may ... the DePuy Synthes Craniomaxillofacial (CMF) Distraction System is an ...
(Date:9/1/2014)... 01, 2014 Beginning Tuesday, September 2nd, ... medical professionals and 10,000 consumers for the annual gathering ... gathering of the nation’s top medical professionals who specializes ... conditions. The week-long event contains more than 120 hours ... available in the pain management field. , MarijuanaDoctors.com is ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2
... presented today,at the Society of Interventional Radiology,s 33rd ... Atlanta metro area, only 18 percent of the,women ... about uterine,fibroid embolization (UFE), a minimally invasive treatment ... a safe, effective,established treatment that has been widely ...
... N.C., March 18 The key to collecting,meaningful ... data. Companies use tools and techniques ranging in ... competitor, to monitoring the air,emissions outside a Competitor,s ... methods and often experiment with new collection,sources to ...
... walking problems , , TUESDAY, March 18 (HealthDay News) -- The ... affects how well older people are able to move around ... matter changes -- called leukoaraiosis -- are common in older ... ages 65 to 84, who underwent walking and balance tests, ...
... Corporation,(Nasdaq: SMTS ) reported net revenues of $8.7 ... 8 percent increase from $8.0 million in the,same period ... to $7.4 million from $6.6,million in the same period ... $1.4 million last year., First quarter income before ...
... March 18 Cardinal Health, a,global provider of products ... care, today announced the appointment of former,Acting Deputy U.S. ... officer, a newly expanded position., Morford, 49, has ... in,public service with the Department of Justice, including serving ...
... Management,Services, Inc. (Nasdaq: BDMS ), operators ... the year ended December 31, 2007. Total,dental ... 3.9%, to $59.4,million. Net revenue increased $1.4 ... earnings before interest, taxes, depreciation, amortization and,non-cash ...
Cached Medicine News:Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 2Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 3Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 4Health News:Balance in Old Age Tied to Brain Changes 2Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 2Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 3Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 4Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 5Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 6Health News:Somanetics Reports Financial Results for the First Quarter of Fiscal 2008 7Health News:Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post 2Health News:Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post 3Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 2Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 3Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 4Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 5Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 6Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 7Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 8
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... The report firstly reviews the basic information of ... manufacturing technology. The report then explores global and ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... FRANKLIN LAKES, N.J. , May 11 ... agonists (LABAs) alone, and not in combination with other ... Food and Drug Administration (FDA) on the risk of ...  This according to a new study from the ...
... , May 11 The DNA Medicine Institute announced today ... from the Bill & Melinda Gates Foundation.  The grant will support an ... M.D. titled "Optomagnetic Finger Scanner for Malaria." , ... Dr. Chan,s project is one of 78 grants announced ...
Cached Medicine Technology:Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 2Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 3Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 4Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 5DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: